Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,370 Cr
up ₹114 Cr vs May 2023
- Stocks held
- 24
- unchanged
- Top 10 weight
- 68.7%
- of the portfolio in its ten largest
- Cash & debt
- 0.9%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2023 it disclosed 24 stocks worth ₹1,370 Cr, up ₹114 Cr from May 2023. Its largest positions were Sun Pharmaceutical Industries Limited (15.6%), Cipla Limited (9.7%), Apollo Hospitals Enterprise Limited (6.9%); the ten largest together made up 68.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.1% of its equity. Cash and debt stood at 0.9%. Compared with May 2023 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
11%
Holds more cash than 11% of peers
What these mean: concentration · cash
Holdings in June 2023
Download CSVEvery line the fund disclosed, with the change against May 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 15.65% | down 0.18 pts | ₹214 Cr | up ₹15.5 Cr | Added |
| Cipla Limited | 9.73% | down 0.23 pts | ₹133 Cr | up ₹8.1 Cr | Added |
| Apollo Hospitals Enterprise Limited | 6.93% | up 0.08 pts | ₹94.9 Cr | up ₹8.9 Cr | Added |
| Lupin Limited | 6.72% | up 0.19 pts | ₹92 Cr | up ₹10 Cr | Added |
| Procter & Gamble Health Limited | 6.09% | down 0.53 pts | ₹83.4 Cr | up ₹32 L | Held |
| Alembic Pharmaceuticals Limited | 5.43% | up 0.34 pts | ₹74.4 Cr | up ₹10.5 Cr | Added |
| Alkem Laboratories Limited | 4.81% | down 0.21 pts | ₹65.9 Cr | up ₹2.9 Cr | Added |
| Suven Pharmaceuticals Limited | 4.56% | up 0.84 pts | ₹62.4 Cr | up ₹15.7 Cr | Added |
| IPCA Laboratories Limited | 4.52% | up 0.12 pts | ₹61.9 Cr | up ₹6.6 Cr | Added |
| Mankind Pharma Limited | 4.29% | up 0.07 pts | ₹58.7 Cr | up ₹5.7 Cr | Added |
| Intuitive Surgical Inc | 3.84% | up 0.12 pts | ₹52.6 Cr | up ₹5.9 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.52% | up 0.40 pts | ₹48.2 Cr | up ₹9.1 Cr | Added |
| Zydus Lifesciences Limited | 3.26% | up 0.20 pts | ₹44.6 Cr | up ₹6.2 Cr | Added |
| Indoco Remedies Limited | 3.02% | down 0.53 pts | ₹41.3 Cr | down ₹3.2 Cr | Trimmed |
| Aarti Drugs Limited | 2.52% | down 0.06 pts | ₹34.5 Cr | up ₹2.1 Cr | Added |
| Globus Medical Inc | 2.39% | up 0.07 pts | ₹32.7 Cr | up ₹3.6 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.37% | up 0.10 pts | ₹32.5 Cr | up ₹3.9 Cr | Added |
| Abbott Laboratories | 2.06% | down 0.04 pts | ₹28.2 Cr | up ₹1.8 Cr | Added |
| Kovai Medical Center and Hospital Limited | 1.89% | down 0.07 pts | ₹25.8 Cr | up ₹1.2 Cr | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.46% | down 0.12 pts | ₹20 Cr | up ₹9 L | Held |
| Taro Pharmaceutical Industries Limited | 1.45% | down 0.07 pts | ₹19.8 Cr | up ₹73 L | Added |
| MedPlus Health Services Limited | 1.09% | down 0.16 pts | ₹14.9 Cr | down ₹71 L | Trimmed |
| Illumina Inc | 0.95% | down 0.12 pts | ₹13 Cr | down ₹37 L | Trimmed |
| Cash, TREPS & receivables | 0.90% | up 0.48 pts | ₹12.3 Cr | up ₹7 Cr | Added |
| Pfizer Limited | 0.42% | down 0.04 pts | ₹5.8 Cr | down ₹4 L | Trimmed |
| Unichem Laboratories Limited | 0.16% | up 0.16 pts | ₹2.1 Cr | up ₹2.1 Cr | New |
What changed, May 2023 to Jun 2023
New New positions (1)
- Unichem Laboratories Limited0.2% · ₹2.1 Cr
Exited Exited (1)
- Dr. Reddy's Laboratories Limitedwas 0.8% · ₹10 Cr
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹15.7 Cr (+0.84% pts)
- Sun Pharmaceutical Industries Limitedup ₹15.5 Cr (−0.18% pts)
- Alembic Pharmaceuticals Limitedup ₹10.5 Cr (+0.34% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2023, the weight rose most in Healthcare Services (+0.3 pts) and Healthcare Equipment & Supplies (+0.2 pts), and fell most in Pharmaceuticals (−0.4 pts) and Retailing (−0.2 pts).
- Healthcare Services13.3% → 13.6%+0.3 pts
- Healthcare Equipment & Supplies6.2% → 6.4%+0.2 pts
- Insurance2.3% → 2.4%+0.1 pts
- Pharmaceuticals5.8% → 5.4%−0.4 pts
- Retailing1.3% → 1.1%−0.2 pts
- Pharmaceuticals & Biotechnology71.2% → 71.1%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2020 | Jun 2022 | Dec 2022 | Mar 2023 | May 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.9% | 57.1% | 63.9% | 69.9% | 71.2% | 71.1% |
| Healthcare Services | 16.8% | 26.0% | 18.9% | 15.2% | 13.3% | 13.6% |
| Healthcare Equipment & Supplies | 2.4% | 5.4% | 7.1% | 6.0% | 6.2% | 6.4% |
| Pharmaceuticals | 10.0% | 7.6% | 6.4% | 5.7% | 5.8% | 5.4% |
| Insurance | 1.9% | 2.5% | 2.6% | 2.2% | 2.3% | 2.4% |
| Retailing | — | 1.3% | 1.0% | 1.1% | 1.3% | 1.1% |
Allocation in Jun 2023change vs May 2023
- Pharmaceuticals & Biotechnology (13)71.1%▼ 0.1 pts
- Healthcare Services (4)13.6%▲ 0.3 pts
- Healthcare Equipment & Supplies (2)6.4%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2023
0.9%
▲ 0.5 pts vs May 2023
- Cash alone
- 0.9%
- cash and net receivables
- A year earlier
- 0.1%
- Jun 2022 · now ▲ 0.8 pts
- Last 12 months
- −<0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.